Clover Corporation Limited

Equities

CLV

AU000000CLV2

Food Processing

Market Closed - Australian S.E. 11:04:07 20/05/2024 am IST 5-day change 1st Jan Change
0.51 AUD -1.92% Intraday chart for Clover Corporation Limited 0.00% -38.18%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Clover Swings to Loss in H1 FY24; Shares Down 16% MT
Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2024 CI
Clover Corporation Limited(ASX:CLV) dropped from S&P/ASX All Ordinaries Index CI
Transcript : Clover Corporation Limited - Shareholder/Analyst Call
Clover Corporation Limited Declares Payment of Final Dividend for the Financial Year 2023 CI
Clover Corporation Limited Declares Fully Franked Final Dividend for the Financial Year Ended 31 July 2023, Payable on 20 November 2023 CI
Clover Corporation Limited Reports Earnings Results for the Full Year Ended July 31, 2023 CI
Clover Corporation Limited(ASX:CLV) dropped from S&P/ASX Emerging Companies Index CI
Clover Corporation Limited Declares Fully Franked Final Dividend for First Half of Financial Year 2023, Payable on 27 April 2023 CI
Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2023 CI
Clover Corporation Limited Reports Earnings Results for the Half Year Ended January 31, 2023 CI
Clover Corporation Seeks Mergers and Acquisitions CI
Transcript : Clover Corporation Limited - Shareholder/Analyst Call
Clover Declares FY22 Final Dividend MT
Clover Corporation Limited Payment of Final Dividend for the Financial Year 2022 CI
Clover Informs Study Results by the South Australian Health and Medical Research Institute CI
Clover Corporation Limited Declares Fully Franked Final Dividend for the Year Ended 31 July 2022, Payable on 22 November 2022 CI
Clover Corporation Limited(ASX:CLV) dropped from S&P Global BMI Index CI
UBS Upgrades Clover to Buy From Neutral, Adjusts Price Target to AU$1.35 From AU$1.40 MT
Clover's Net Profit After Tax Jumps 18.8% in FY22 MT
Clover Corporation Limited Reports Earnings Results for the Full Year Ended July 31, 2022 CI
Clover Improves Cognitive Development of Prematurely Born Children MT
Clover Corporation Limited Announces the Release of New Results from the Clinical Research Study Called the N3RO Trial CI
UBS Downgrades Clover to Neutral From Buy, Adjusts Price Target to AU$1.4 From AU$1.85 MT
Clover Records Lower Fiscal H1 Profit MT
Chart Clover Corporation Limited
More charts
Clover Corporation Limited is focused on technology, new product development and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. The Company’s microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formula, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.51 AUD
Average target price
0.6 AUD
Spread / Average Target
+17.65%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CLV Stock
  4. News Clover Corporation Limited
  5. Clover Swings to Loss in H1 FY24; Shares Down 16%
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW